Released: June 29, 2018

Defense Health Program
US Army Medical Research and Materiel Command (USAMRMC)
Accelerating Innovation in Military Medicine (AIMM)
Anticipated Funding Opportunity for Fiscal Year 2018 (FY18)

The FY18 AIMM Program Announcement and General Application Instructions for the following award mechanism are anticipated to be posted on in August 2018. Pre-application and application deadlines will be available when the Program Announcement is released. This pre-announcement should not be construed as an obligation by the Government, and funding of research projects received in response to the Program Announcement is contingent on the availability of Federal funds.

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) Research and Development Directorate (J9) manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

Award Mechanism Eligibility Key Mechanism Elements Funding
AIMM Research Award Independent investigators at all academic levels (or equivalent)
  • Supports highly creative and conceptually innovative high-risk research with the potential to accelerate critical discoveries or major advancements that will significantly impact military health and medicine
  • Supports novel research concepts and development of enabling technologies; not intended to support incremental advances on previous or ongoing work
  • Supports applied research efforts that initiate or enhance potential game-changers; clinical trials are not allowed.
  • Projects proposed should be relevant to at least one DoD medical research program area. Cross-cutting research projects with the potential to benefit multiple DoD medical research program areas are highly encouraged.
  • Applications using synthetic or systems biology-based approaches are highly encouraged
  • Preliminary data that are relevant to the proposed research are encouraged, but not required.
  • Preproposal is required; application submission is by invitation only
  • Maximum funding of $350,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 18 months.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at prior to the pre-application deadline. All applications must conform to the final Program Announcement and General Application Instructions that will be available for electronic downloading from the website at The application package containing the required forms for each award mechanism will also be found on A listing of all USAMRMC funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government’s single-entry portal, Submission deadlines are not available until the Program Announcement is released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at For more information about other CDMRP-administered programs, please visit the CDMRP website (

Point of Contact:

CDMRP Public Affairs

Last updated Thursday, May 26, 2022